Skip to content

The Chinese Multi-Center Screening Trial

The Chinese Multi-Center Screening Trial: The Prevention of Cervical Cancer Using Self-collection as the Primary Screen

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-EOC-16008456
Enrollment
Unknown
Registered
2016-05-11
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer and Pre-Cancer

Interventions

Selected target population:1 self-sampling and 1 direct-sampling on all participants and 2 pseudo-self-sampling on participants in a high risk subset will be used for multiple assays
samples with positive test results will be followed by referral for colposcopy and biopsy.

Sponsors

China International Exchange and Promotion Association for for Medical and Health Care
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 59 Years

Inclusion criteria

Inclusion criteria: Eligibility Criteria: non-pregnant, 30-59 years of age, no screening for at least 3 years, no prior hysterectomy, no prior radiation, and willing to return for positive management if indicated by the primary tests.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Pregnant, screening in the previous 3 years, history of a hysterectomy, pelvic radiation therapy, or not willing to return for positive management if indicated by the primary tests.

Design outcomes

Primary

MeasureTime frame
High -Risk HPV;Cervical Cancer and Pre-Cancer;Specificity and Sensitivity for CIN3+ and CIN2+;

Countries

China

Contacts

Public ContactProfessor Ruifang Wu

Peking University Shenzhen Hospital

wurf100@126.com+86 13827433039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026